No image available for this title

LITERATURE

A Review of Nebivolol Pharmacology and Clinical Evidence


Nebivolol is a highly selective b1-adrenergic receptor antagonist with a pharmacologic profile that differs from those of other drugs in its class. In addition to cardioselectivity mediated via b1 receptor blockade, nebivolol induces nitric oxide-mediated vasodilation by stimulating
endothelial nitric oxide synthase via b3 agonism.


Availability

Nevodio-001Available

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
Drugs
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous